Bendamustin as part of conditioning regimen for autologous stem cell transplantation (ASCT) in patients with aggressive lymphomas: A phase 2 study fromspanish geltamo group
Identifiers
Identifiers
Date issued
2013Journal title
HEMATOLOGICAL ONCOLOGY
Type of content
Publicación de congreso